Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort

Overview of attention for article published in Scientific Reports, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 5 X users

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 20,421 followers.

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort https://t.co/yTio8ueH8m

RT @mike_lustgarten: "Patients with lower ergothioneine levels had a 12% higher rate of AD progression" Multiomics analysis to explore blo…

fwiw, I don't think that the age-related decline for ergothionine is exclusively because of decreased intake, but instead because of a relatively high gut pH I'll cover that hypothesis in a future video... https://t.co/b8biNcrqgV

"Patients with lower ergothioneine levels had a 12% higher rate of AD progression" Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort https://t.co/yTio8ue9iO

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.